Ignyta appoints new CMO
This article was originally published in Scrip
Executive Summary
Ignyta, an oncology precision medicine biotechnology company, has named Adrian Senderowicz, chief medical officer and senior vice-president, clinical development and regulatory affairs. Prior to joining San Diego, California-based Ignyta Dr Senderowicz was vice-president, global regulatory oncology at Sanofi, a position he held from September 2013 to August 2014.